Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Checkpoint Communiqué
(CPC)
last updated: 22 Jul 2026
STOP Project – Stopping Transmission of Intestinal Parasites
-
ABSCH-CP-GB-207653-5 Checkpoint The Office for Product Safety and Standards (OPSS)The National Focal Point in the Department for Environment, Food & Rural Affairs (Defra) is responsible for:
- requesting due diligence declarations from users on receipt of research funding;
- the receipt of due diligence declarations from users conducting research and development in the UK at two checkpoints (receipt of research funding and placing a product on the market);- submitting due diligence declarations as checkpoint communiqués on the ABS Clearing House.
The Office for Product Safety and Standards (OPSS) is responsible for:- monitoring user compliance in the UK;- where necessary enforcing compliance obligations of UK users of genetic resources and genetic resources associated with traditional knowledge.
Note: The ABS Clearing-House does not guarantee the receipt of automatically generated emails.
Competent National Authority:The Office for Product Safety and Standards (OPSS), Department for Business and Trade (DBT) ()Stanton Avenue, TeddingtonLondon,
TW11 0JZ, United Kingdom of Great Britain and Northern IrelandPhone: +44 121 345 1201,Fax:
Organization:Ethiopian Biodiversity Institute (EBI)Government agency (National/Federal)Comoros StreetAddis Ababa,
, EthiopiaPhone: +251-116-61 22 44, +251-116-61 56 07,Fax: +251-116-61 37 22, +251-116-61 25 42,Email: info@ebi.gov.et,Website: https://ebi.gov.et/,
The internationally recognized certificate of compliance (IRCC) is not available
- Ethiopia
Organization:Ethiopian Biodiversity Institute (EBI)Government agency (National/Federal)Comoros StreetAddis Ababa,
, EthiopiaPhone: +251-116-61 22 44, +251-116-61 56 07,Fax: +251-116-61 37 22, +251-116-61 25 42,Email: info@ebi.gov.et,Website: https://ebi.gov.et/,
Soil-transmitted helminth worm DNA and eggs and/or infected stool samples.
*
*
- Material Export Permit with reference EBI-71/1338/2016 dated 25 June 2024 signed on behalf of Sponsor (n.d.); on behalf of Provider on 18 June 2024 and on behalf of the Researcher on 24 May 2024
- Material Export Permit with reference EBI-71/9028/2015 dated 8 June 2023 signed on behalf of the Sponsor (n.d.), on behalf of the Provider on 25 May 2023 and on behalf of the Researcher (n.d.)
*
- Mutually Agreed Terms mentioned in Material Export Permit with reference EBI-71/1338/2016 dated 25 June 2024 signed on behalf of Sponsor (n.d.); on behalf of Provider on 18 June 2024 and on behalf of the Researcher on 24 May 2024
- Mutually Agreed Terms mentions in Material Export Permit with reference EBI-71/9028/2015 dated 8 June 2023 signed on behalf of the Sponsor (n.d.), on behalf of the Provider on 25 May 2023 and on behalf of the Researcher (n.d.)
*
2025-01-30
The aim of the STOP project is to find a more effective treatment for the treatment of intestinal worms, also called soil-transmitted helminths.
The Wellcome Sanger Institute will use whole genome sequencing to identify novel genetic variants which predict treatment resistance, and to explore the gut microbiome and its role in the pharmacokinetics and efficacy of anthelmintics.
*
The Wellcome Sanger Institute will use whole genome sequencing to identify novel genetic variants which predict treatment resistance, and to explore the gut microbiome and its role in the pharmacokinetics and efficacy of anthelmintics.
*
Organization:Wellcome Sanger Institute ()Wellcome Genome Campus HinxtonCambridge,
CB10 1SA, United Kingdom of Great Britain and Northern IrelandPhone: +44 (0)1223 496920,Fax: +44 (0)1223 494919,Email: nagoya@sanger.ac.uk,Website: https://www.sanger.ac.uk/,
2025-09-22
